Real-world intravascular ultrasound (IVUS) use in percutaneous intervention-naive patients is determined predominantly by operator, patient, and lesion characteristics.

ABSTRACT:

Background

Intravascular Ultrasound (IVUS) has been shown to improve clinical outcomes in patients undergoing percutaneous intervention (PCI) in numerous trials. However, it is still underutilized outside of trial settings, and most trials include a significant proportion of patients with prior PCI. The aim of this study is to look at real-world use and outcomes in PCI-naïve patients who undergo IVUS-guided intervention.

Methods and results

Prospectively collected data from 10,574 consecutive patients undergoing their index PCI was retrospectively analyzed. 455 (4.3%) patients underwent IVUS, with a median follow-up of 4.6 years. Patients undergoing IVUS had higher levels of comorbidities including diabetes (27.5% vs. 19.7%, p < 0.001), hypertension (58.0% vs. 47.9%,

SUBMITTER: Tindale A 

PROVIDER: S-EPMC9678943 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature